Cuban anti-cancer vaccines soon to be available in Serbia

Certain quantities of CimaVax-EGF, a Cuban-developed drug used for lung cancer therapy, will soon be available in Serbia.

A memorandum on the procurement of 1,680 units of the CimaVax-EGF vaccine has been signed between the Cuban CIMAB and the Serbian Institute of Virology, Vaccines and Sera Torlak, the Ministry of Health said on its official website.

Continue reading on: